RSS

Archivi categoria: fosforo e iperfosforemia

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial – American Journal of Kidney Diseases

Sorgente: Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial – American Journal of Kidney Diseases

Annunci
 

Phosphate – a “driver” of mortality in kidney patientsIl nuemico numero uno dei pazienti nefropatici: il fosforo

Sorgente: Phosphate – a “driver” of mortality in kidney patients

Sorgente: The role of phosphate in kidney disease : Nature Reviews Nephrology : Nature Research

 

 

Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials – American Journal of Kidney Diseases

Sorgente: Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials – American Journal of Kidney Diseases

 

Cutting Phosphorus Additives Reduces Hyperphosphatemia – Renal and Urology News

A majority of intervention patients attained serum phosphorus levels below 5.5 mg/dL, a small study verifies.

Sorgente: Cutting Phosphorus Additives Reduces Hyperphosphatemia – Renal and Urology News

 

Hypercalcemia in Emergency Medicine: Background, Pathophysiology, Epidemiology Ipercalcemia in acuto

Hypercalcemia is a disorder that most commonly results from malignancy or primary hyperparathyroidism. Other, less common, causes of elevated calcium include increased intake or absorption, granulomatous disease, immobilization, and thiazide diuretic use.

Sorgente: Hypercalcemia in Emergency Medicine: Background, Pathophysiology, Epidemiology

 

Phosphorus and Your CKD Diet – The National Kidney Foundation

What is phosphorus? Phosphorus is a mineral found in your bones. Along with calcium, phosphorus is needed to build strong healthy bones, as well as, keeping other parts of your body healthy.

Sorgente: Phosphorus and Your CKD Diet – The National Kidney Foundation

 

Study: Phosphate Binders Do Not Lower Death Risk – Renal and Urology News

Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer.

Sorgente: Study: Phosphate Binders Do Not Lower Death Risk – Renal and Urology News

 
 
%d blogger hanno fatto clic su Mi Piace per questo: